{"id":24079,"date":"2024-04-29T11:52:16","date_gmt":"2024-04-29T09:52:16","guid":{"rendered":"https:\/\/ggba.swiss\/unibe-spin-off-risklick-unveils-ai-tool-to-streamline-clinical-trials\/"},"modified":"2024-04-29T11:54:35","modified_gmt":"2024-04-29T09:54:35","slug":"risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/","title":{"rendered":"Risklick d\u00e9voile un outil d&rsquo;IA pour bouleverser le paysage des essais cliniques"},"content":{"rendered":"\n<p>Le d\u00e9veloppement de nouvelles th\u00e9rapies est un processus long et co\u00fbteux, qui prend en moyenne dix ans et co\u00fbte jusqu&rsquo;\u00e0 deux milliards de dollars aux entreprises pharmaceutiques. Une part importante de ces co\u00fbts et de ce temps est attribu\u00e9e aux essais cliniques, qui sont obligatoires pour valider les nouveaux traitements avant leur mise sur le march\u00e9. La complexit\u00e9 et la dur\u00e9e de ces essais entra\u00eenent souvent des retards et des \u00e9checs, ce qui affecte \u00e0 la fois le co\u00fbt et la disponibilit\u00e9 des nouveaux traitements.<\/p>\n\n\n\n<p>\u00ab&nbsp;L&rsquo;\u00e9laboration d&rsquo;un protocole peut prendre jusqu&rsquo;\u00e0 12 mois de travail intensif. La moindre erreur peut avoir de graves cons\u00e9quences&nbsp;\u00bb, a d\u00e9clar\u00e9 Poorya Amini, cofondateur et CEO de <a href=\"https:\/\/www.risklick.ch\/\">Risklick<\/a>. Pour r\u00e9soudre ces probl\u00e8mes, Risklick a introduit <a href=\"https:\/\/www.risklick.ch\/#protocol-ai-benefits\">Protocol AI<\/a>, que M. Amini d\u00e9crit comme une \u00ab&nbsp;solution pionni\u00e8re&nbsp;\u00bb qui r\u00e9duit \u00e0 la fois le temps et le co\u00fbt des essais cliniques jusqu&rsquo;\u00e0 35 %.<\/p>\n\n\n\n<p>Protocol AI utilise des technologies avanc\u00e9es telles que le traitement du langage naturel (NLP), les grands mod\u00e8les de langage (LLM) et l&rsquo;apprentissage automatique (ML) pour optimiser la s\u00e9lection et l&rsquo;int\u00e9gration des donn\u00e9es cliniques existantes. Cela facilite la prise de d\u00e9cision fond\u00e9e sur des donn\u00e9es probantes et permet la r\u00e9daction automatique de protocoles d&rsquo;essais cliniques en quelques minutes.<\/p>\n\n\n\n<p>L&rsquo;impact du logiciel va au-del\u00e0 de la simplification de l&rsquo;\u00e9laboration des protocoles. Il augmente \u00e9galement les chances de succ\u00e8s d&rsquo;un essai, ce qui en fait un outil essentiel pour l&rsquo;avenir de l&rsquo;innovation m\u00e9dicale. Protocol AI a d\u00e9j\u00e0 suscit\u00e9 l&rsquo;int\u00e9r\u00eat d&rsquo;acteurs majeurs de l&rsquo;industrie, notamment <a href=\"https:\/\/www.debiopharm.com\/\">Debiopharm<\/a> et Integrated Scientific Services (<a href=\"https:\/\/www.iss-ag.ch\/en\">ISS AG<\/a>), qui ont ainsi pu am\u00e9liorer leurs capacit\u00e9s de recherche et de d\u00e9veloppement.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Transformer le mod\u00e8le des essais cliniques<\/h4>\n\n\n\n<p>Dans le communiqu\u00e9 de presse de Risklick, C\u00e9dric Odje de Debiopharm a soulign\u00e9 l&rsquo;importance strat\u00e9gique de leur investissement dans la start-up bernoise, notant que Protocol AI acc\u00e9l\u00e8re la mise \u00e0 disposition de traitements innovants tout en garantissant des conceptions d&rsquo;essais efficaces et une conformit\u00e9 solide. De m\u00eame, Michel Weber d&rsquo;ISS AG a soulign\u00e9 la capacit\u00e9 du logiciel \u00e0 am\u00e9liorer la conception des investigations cliniques, en soutenant la g\u00e9n\u00e9ration de donn\u00e9es th\u00e9rapeutiques pr\u00e9cises pour les dispositifs m\u00e9dicaux, les m\u00e9dicaments num\u00e9riques et les diagnostics in vitro (IVD).<\/p>\n\n\n\n<p>Enfin, Paul Miller, Vice-pr\u00e9sident de la strat\u00e9gie commerciale d&rsquo;<a href=\"https:\/\/www.advancedclinical.com\/\">Advanced Clinical<\/a> a \u00e9galement fait l&rsquo;\u00e9loge de Protocol AI pour sa capacit\u00e9 \u00e0 minimiser les d\u00e9formations de l&rsquo;IA et \u00e0 extraire des donn\u00e9es valid\u00e9es \u00e0 partir de divers registres, ce qui peut \u00ab&nbsp;r\u00e9volutionner la m\u00e9thodologie des essais cliniques&nbsp;\u00bb.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Risklick, une spin-off de l&rsquo;Universit\u00e9 de Berne, a d\u00e9voil\u00e9 son logiciel Protocol AI, con\u00e7u pour transformer le paysage du d\u00e9veloppement pharmaceutique.<\/p>\n","protected":false},"author":6,"featured_media":24076,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1179,1183,1169,1171,1142,1157],"class_list":["post-24079","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-artificial-intelligence-fr-2","tag-big-data-en-fr","tag-biotech-fr-2","tag-pharma-fr-2","tag-rd-fr-2","tag-software-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Risklick d\u00e9voile un outil d&#039;IA pour r\u00e9volutionner les essais cliniques<\/title>\n<meta name=\"description\" content=\"Risklick a d\u00e9voil\u00e9 son logiciel Protocol AI, con\u00e7u pour transformer le paysage du d\u00e9veloppement pharmaceutique.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Risklick d\u00e9voile un outil d&#039;IA pour r\u00e9volutionner les essais cliniques\" \/>\n<meta property=\"og:description\" content=\"Risklick a d\u00e9voil\u00e9 son logiciel Protocol AI, con\u00e7u pour transformer le paysage du d\u00e9veloppement pharmaceutique.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-29T09:52:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-29T09:54:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2024\/04\/Protocol-AI-Risklick-1180x811-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Risklick d\u00e9voile un outil d&rsquo;IA pour bouleverser le paysage des essais cliniques\",\"datePublished\":\"2024-04-29T09:52:16+00:00\",\"dateModified\":\"2024-04-29T09:54:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/\"},\"wordCount\":488,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/04\/Protocol-AI-Risklick-1180x811-1.jpg\",\"keywords\":[\"Artificial Intelligence\",\"Big Data\",\"Biotech\",\"Pharma\",\"R&amp;D\",\"Software\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/\",\"name\":\"Risklick d\u00e9voile un outil d'IA pour r\u00e9volutionner les essais cliniques\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/04\/Protocol-AI-Risklick-1180x811-1.jpg\",\"datePublished\":\"2024-04-29T09:52:16+00:00\",\"dateModified\":\"2024-04-29T09:54:35+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Risklick a d\u00e9voil\u00e9 son logiciel Protocol AI, con\u00e7u pour transformer le paysage du d\u00e9veloppement pharmaceutique.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/04\/Protocol-AI-Risklick-1180x811-1.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/04\/Protocol-AI-Risklick-1180x811-1.jpg\",\"width\":1180,\"height\":811,\"caption\":\"Protocol AI utilise l'intelligence artificielle pour faciliter le d\u00e9veloppement des essais cliniques, en r\u00e9duisant les co\u00fbts, en am\u00e9liorant les normes de s\u00e9curit\u00e9 et en bouleversant potentiellement le domaine.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Risklick d\u00e9voile un outil d&#8217;IA pour bouleverser le paysage des essais cliniques\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Risklick d\u00e9voile un outil d'IA pour r\u00e9volutionner les essais cliniques","description":"Risklick a d\u00e9voil\u00e9 son logiciel Protocol AI, con\u00e7u pour transformer le paysage du d\u00e9veloppement pharmaceutique.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/","og_locale":"fr_FR","og_type":"article","og_title":"Risklick d\u00e9voile un outil d'IA pour r\u00e9volutionner les essais cliniques","og_description":"Risklick a d\u00e9voil\u00e9 son logiciel Protocol AI, con\u00e7u pour transformer le paysage du d\u00e9veloppement pharmaceutique.","og_url":"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2024-04-29T09:52:16+00:00","article_modified_time":"2024-04-29T09:54:35+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/04\/Protocol-AI-Risklick-1180x811-1.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Risklick d\u00e9voile un outil d&rsquo;IA pour bouleverser le paysage des essais cliniques","datePublished":"2024-04-29T09:52:16+00:00","dateModified":"2024-04-29T09:54:35+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/"},"wordCount":488,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/04\/Protocol-AI-Risklick-1180x811-1.jpg","keywords":["Artificial Intelligence","Big Data","Biotech","Pharma","R&amp;D","Software"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/","url":"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/","name":"Risklick d\u00e9voile un outil d'IA pour r\u00e9volutionner les essais cliniques","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/04\/Protocol-AI-Risklick-1180x811-1.jpg","datePublished":"2024-04-29T09:52:16+00:00","dateModified":"2024-04-29T09:54:35+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Risklick a d\u00e9voil\u00e9 son logiciel Protocol AI, con\u00e7u pour transformer le paysage du d\u00e9veloppement pharmaceutique.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/04\/Protocol-AI-Risklick-1180x811-1.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/04\/Protocol-AI-Risklick-1180x811-1.jpg","width":1180,"height":811,"caption":"Protocol AI utilise l'intelligence artificielle pour faciliter le d\u00e9veloppement des essais cliniques, en r\u00e9duisant les co\u00fbts, en am\u00e9liorant les normes de s\u00e9curit\u00e9 et en bouleversant potentiellement le domaine."},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/risklick-devoile-un-outil-dia-pour-bouleverser-le-paysage-des-essais-cliniques\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Risklick d\u00e9voile un outil d&#8217;IA pour bouleverser le paysage des essais cliniques"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/24079","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=24079"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/24079\/revisions"}],"predecessor-version":[{"id":24081,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/24079\/revisions\/24081"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/24076"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=24079"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=24079"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=24079"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}